Details for Patent: 10,259,791
✉ Email this page to a colleague
Which drugs does patent 10,259,791 protect, and when does it expire?
Patent 10,259,791 protects LENVIMA and is included in one NDA.
Protection for LENVIMA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-nine patent family members in twenty-four countries.
Summary for Patent: 10,259,791
| Title: | High-purity quinoline derivative and method for manufacturing same |
| Abstract: | Provided is a compound represented by formula (IV) or a salt thereof, wherein the content of the compound represented by formula (I) is 350 ppm by mass or less. ##STR00001## |
| Inventor(s): | Nakamura; Taiju (Kamisu, JP), Abe; Taichi (Kamisu, JP), Miyashita; Yusuke (Kamisu, JP), Kuroda; Hirofumi (Kamisu, JP), Ayata; Yusuke (Kamisu, JP), Akao; Atsushi (Kamisu, JP) |
| Assignee: | Eisai R&D Management Co., Ltd. (Tokyo, JP) |
| Application Number: | 15/503,108 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,259,791 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; |
More… ↓ |
Drugs Protected by US Patent 10,259,791
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-001 | Feb 13, 2015 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-002 | Feb 13, 2015 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,259,791
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2014-174062 | Aug 28, 2014 |
| Japan | 2015-034729 | Feb 25, 2015 |
| PCT Information | |||
| PCT Filed | August 26, 2015 | PCT Application Number: | PCT/JP2015/073946 |
| PCT Publication Date: | March 03, 2016 | PCT Publication Number: | WO2016/031841 |
International Family Members for US Patent 10,259,791
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 101695 | ⤷ Subscribe | |||
| Australia | 2015309862 | ⤷ Subscribe | |||
| Brazil | 112017002827 | ⤷ Subscribe | |||
| Canada | 2957005 | ⤷ Subscribe | |||
| China | 106660964 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
